Table 2.
Vaccinated (n = 109) | Non-Vaccinated (n = 92) | p-Value | |
---|---|---|---|
Number of post-COVID symptoms | 2.5 ± 1.1 | 2.5 ± 1.3 | 0.757 |
Post-COVID Symptomatology | |||
Fatigue | 86 (78.9%) | 68 (73.9%) | 0.687 |
Dyspnea at exertion * | 93 (85.3%) | 16 (17.4%) | <0.001 |
Pain Symptoms (excluding headache) | 44 (40.4%) | 39 (42.4%) | 0.823 |
Memory Loss | 22 (20.2%) | 14 (15.2%) | 0.407 |
Hair Loss | 33 (30.3%) | 40 (43.5%) | 0.122 |
Headache | 14 (12.9%) | 17 (18.5%) | 0.310 |
Dyspnea at rest | 18 (16.5%) | 8 (8.9%) | 0.252 |
Gastrointestinal Problems | 16 (14.7%) | 12 (13.05%) | 0.756 |
Cognitive Blurring-Frain Fog | 12 (11.0%) | 10 (10.9%) | 0.976 |
Throat Pain | 11 (10.1%) | 7 (7.6%) | 0.558 |
Skin Rashes | 6 (5.5%) | 4 (4.35%) | 0.714 |
Ageusia | 6 (5.5%) | 4 (4.35%) | 0.714 |
Anosmia | 9 (8.25%) | 3 (3.25%) | 0.149 |
Ocular Problems | 7 (6.4%) | 2 (2.2%) | 0.156 |
Palpitations-Tachycardia | 2 (1.8%) | 6 (6.5%) | 0.101 |
Concentration Loss | 2 (1.8%) | 4 (4.35%) | 0.304 |
Voice Problems | 2 (1.8%) | 2 (2.2%) | 0.865 |
Psychological and Emotional Symptoms | |||
HADS-A (0–21) | 3.5 ± 3.2 | 2.5 ± 3.0 | 0.245 |
Anxiety (HADS-A ≥12 points) | 2 (1.8%) | 1 (1.1%) | 0.902 |
HADS-D (0–21) | 3.8 ± 3.3 | 2.5 ± 3.3 | 0.499 |
Depression (HADS-D ≥10 points) | 5 (4.6%) | 5 (5.4%) | 0.891 |
Sleep Quality (0–21) * | 7.6 ± 3.45 | 6.5 ± 3.7 | 0.025 |
Poor Sleep Quality (PSQI ≥8 points) * | 51 (46.8%) | 27 (29.35%) | 0.03 |
* Significant differences between vaccinated and non-vaccinated groups (p < 0.05).